Scinai Immunotherapeutics... (SCNI)
3.42
-0.03 (-0.87%)
At close: Jan 15, 2025, 11:09 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 167.98K | 76.22K | 66.96K | 73.42K |
| Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -167.98K | -76.22K | -66.96K | -73.42K |
| Operating Income | -9.71M | -11.06M | -10.87M | 2.28M | -22.69M | -20.61M | -6.80M | -3.09M | -2.90M | -2.09M | -2.20M | -2.38M | -2.30M | -2.54M | -1.17M | -1.30M |
| Interest Income | 122.68K | 8.10M | 928.76 | -9.71K | 8.30K | 1.35M | 5.04K | 14.38K | 2.83K | 21.19K | 37.80K | 65.04K | 129.34K | 85.62K | 8.66K | 89.89K |
| Pretax Income | -6.50M | -5.80M | -8.21M | -1.39M | -31.62M | -23.46M | -9.93M | -2.38M | -2.62M | -1.99M | -2.32M | -2.43M | -2.16M | -2.49M | -1.17M | -1.21M |
| Net Income | -6.50M | -5.80M | -8.21M | -1.39M | -31.62M | -23.46M | -9.93M | -2.38M | -2.62M | -1.99M | -2.32M | -2.43M | -2.16M | -2.49M | -1.17M | -1.21M |
| Selling & General & Admin | 4.50M | 5.30M | 7.63M | 5.19M | 2.81M | 1.38M | 1.40M | 1.07M | 871.81K | 680.13K | 631.56K | 574.69K | 602.75K | 668.83K | 299.68K | 343.07K |
| Research & Development | 5.21M | 5.76M | 3.25M | 16.01M | 19.88M | 19.27M | 5.58M | 2.44M | 2.76M | 1.65M | 1.94M | 1.61M | 1.53M | 1.80M | 805.34K | 882.39K |
| Other Expenses | n/a | n/a | n/a | -23.49M | 1.00 | -38.24K | -185.65K | -416.06K | -726.29K | -243.56K | -366.82K | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 9.71M | 11.06M | 10.87M | -2.28M | 22.69M | 20.61M | 6.80M | 3.09M | 2.90M | 2.09M | 2.20M | 2.19M | 2.13M | 2.47M | 1.11M | 1.23M |
| Interest Expense | -317 | 5.05M | -3.15M | 338.76K | 4.28M | 3.78M | -129.95 | 100.00 | 7.80 | 1.69K | -1.43K | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 9.71M | 11.06M | 10.87M | -2.28M | 22.69M | 20.61M | 6.80M | 3.09M | 2.90M | 2.09M | 2.20M | 2.38M | 2.30M | 2.54M | 1.17M | 1.30M |
| Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 390.66K | 188.52K | 141.14K | 110.81K | 81.66K | 65.35K | 50.26K | 33.77K | 26.38K | 13.57K | 11.99K | 10.53K | 9.64K | 8.91K | 6.73K | 6.38K |
| Shares Outstanding (Diluted) | 390.66K | 188.52K | 141.14K | 110.81K | 81.66K | 65.36K | 50.26K | 33.77K | 26.38K | 13.57K | 11.99K | 10.53K | 9.64K | 8.91K | n/a | 6.38K |
| EPS (Basic) | -16.64 | -30.74 | -58.14 | -12.51 | -387.21 | -358.95 | -197.58 | -70.58 | -99.22 | -146.8 | -193.35 | -230.45 | -223.97 | -279.13 | -173.14 | -189.82 |
| EPS (Diluted) | -16.64 | -30.74 | -58.14 | -12.51 | -387.21 | -358.95 | -197.58 | -70.58 | -99.22 | -146.8 | -193.33 | -230.45 | -223.97 | -279.13 | n/a | -189.82 |
| EBITDA | -9.19M | -10.50M | -10.39M | 2.75M | -22.21M | -20.54M | -6.67M | -2.93M | -2.74M | -1.92M | -2.00M | -2.24M | -1.99M | -2.41M | -1.10M | -1.14M |
| Depreciation & Amortization | 514.00K | 562.00K | 471.00K | 468.56K | 461.69K | 69.53K | 123.55K | 162.32K | 161.62K | 173.75K | 204.46K | 190.18K | 167.98K | 76.22K | 66.96K | 73.42K |